Press Releases

Our leading subject matter experts share their insightful analysis and points of view to help you stay abreast of industry trends

November

03

2021

MMIT Announces Winners of the Sixth-Annual Specialty Pharmacy Patient Choice Awards

Winners in each of the four categories were announced at a virtual awards ceremony on Tuesday, Nov. 2.

Nov. 3, 2021, Yardley, PA — Managed Markets Insight & Technology (MMIT), the trusted go-to-market partner on solving the “what and why” of market access—so that patients don’t face delays when trying to access lifesaving drugs—has announced the winners of the sixth-annual Specialty Pharmacy Patient Choice Awards.

MMIT hosted a virtual awards ceremony…

© 2026 MMIT

October

08

2021

Exclusive AIS Health Data Shows How Much Health Insurer CEOs Were Paid in 2020

Although some health insurers reported record-high profits as the COVID-19 pandemic drove down routine care utilization, that trend did not translate to big compensation bumps for some of the highest-paid insurer CEOs.

Washington, DC, Oct 08, 2021 (GLOBE NEWSWIRE) — Only two CEOs at the six largest publicly traded health insurers saw their total compensation increase in 2020 compared with 2019 — Cigna Corp.’s David Cordani, and…

© 2026 MMIT

September

28

2021

MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making

The move will result in a disruptive, market-leading analytics platform that provides on-demand insights across dozens of normalized real-world evidence and market access data sets that support decision-making from pipeline to prescription

September 28, 2021, Yardley, PA — Managed Markets Insight & Technology (MMIT) and Evaluate (a Welsh, Carson, Anderson & Stowe and Hg portfolio company)—which joined forces last month to become a $1.6 billion global pharma commercial intelligence provider—announced the…

© 2026 MMIT

August

20

2021

MMIT and Evaluate Join Forces to Offer an End-to-End View of the Pharmaceutical Market Landscape

By combining their technology, data and expertise, MMIT and Evaluate will become a $1.6 billion global pharma commercial intelligence provider

August 20, 2021, Yardley, PA — Managed Markets Insight & Technology (MMIT), LLC, the trusted go-to-market partner solely focused on solving the “what and why” of market access, has joined forces with London-based Evaluate, a leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry. This newly merged…

© 2026 MMIT

August

02

2021

MMIT Announces Sixth-Annual Specialty Pharmacy Patient Choice Awards Finalists

Finalists across four categories represent leading specialty pharmacies with a dedication to top-notch customer satisfaction.

Aug. 3, 2021, Yardley, PA – Managed Markets Insight & Technology (MMIT), the trusted go-to-market partner solely focused on solving the “what and why” of market access—so that patients don’t face delays when trying to access lifesaving drugs—has announced the finalists of the sixth-annual Specialty Pharmacy Patient Choice Awards—based on patient satisfaction survey results from the previous year.

© 2026 MMIT

June

03

2021

Exclusive AIS Health Enrollment Data Shows Which Plans Gained During the Medicare Open Enrollment Season

Medicare Advantage organizations that won enrollees in the fall Annual Election Period tended to rack up membership gains in the spring Open Enrollment Period

Washington, DC, Jun 03, 2021 (GLOBE NEWSWIRE) — Medicare Advantage enrollment grew just 1% during the recent 2021 Open Enrollment Period that ran from January to March, compared with growth of 7% during the preceding Annual Election Period, reports Radar on Medicare Advantage,…

© 2026 MMIT

April

27

2021

The combined data, technologies and expertise of both organizations will positively impact patient access to life saving treatments

April 27, 2021, Yardley, PA – Managed Markets Insight & Technology, LLC. (MMIT), the trusted go-to-market partner solely focused on solving the “what and why” of market access—so that patients don’t face delays when trying to access lifesaving drugs—announced today that it will unite with The Dedham Group to smooth and enhance access to therapy.

As the preeminent U.S. market oncology and specialty partner…

© 2026 MMIT
Featured
mmit-patient-choice-awards-finalists

MMIT Announces Finalists of the 11th Specialty Pharmacy Patient Choice Awards

Winners-Tenth-Annual-Specialty-Pharmacy-Patient-Choice-Awards

MMIT Announces Winners of the Tenth Annual Specialty Pharmacy Patient Choice Awards

mmit-patient-choice-awards-finalists

MMIT Announces Finalists of the Tenth Specialty Pharmacy Patient Choice Awards

Topics
Stay In Touch

Be the first to know about new arrivals and promotions

Reducing Risk: 5 Steps for a Fearless Launch